Comparison of the Impact of Metformin and Calcitropin in Treating Polycystic Ovaries in Infertile Women

Comparison of the Impact of Calcitropin and Metformin as Adjunctive Therapy in Treating infertility in Women with Polycystic Ovary Syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140422017388N3

Enrollment

Registered

2020-09-22

Start date

2019-04-21

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Polycystic ovaries, infertility. Condition 2: Infertility. Polycystic ovarian syndrome Female infertility, unspecified

Interventions

Intervention 1: Intervention group: Calcitrapin - People with polycystic ovary syndrome who have the inclusion criteria are placed in the intervention group and receive calcitrapin every twelve hours

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women aged 20-45 years I.e., first pregnancy, oliguria or menstrual disorders, clinical signs such as hyperandrogenism, no history of drug use for menstrual disorders in the last three months without any signs of infertility No male factor in the partner

Exclusion criteria

Exclusion criteria: Absence of inclusion criteria

Design outcomes

Primary

Measure	Time frame
Infertile women with polycystic ovaries. Timepoint: Three months after taking the drug. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Houshmandi

Ardabil University of Medical Sciences

sousan2020@gmail.com+98 45 3324 2327

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026